Amino acid-based formula with synbiotics for cow's milk protein allergy: a real-world study of symptom evolution and quality-of-life outcomes
Frontiers in Pediatrics · 06.07.2026 · 14
DOI: 10.3389/fped.2026.1864706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 06.07.2026. Verfasst von Sebastián Ramiro Soria und 11 weiteren Autor:innen. Beteiligte Einrichtung: CEP Pediatric Specialty Clinics, San Miguel de Tucumán, Argentina. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cow's milk protein allergy (CMPA) is a common early-life food allergy. Evidence from routine care settings may complement randomized trials by describing symptom trajectories in heterogeneous populations.
Objective
This study aimed to describe changes in symptom scores and caregiver-reported outcomes over 28 days following initiation of an amino acid-based formula containing synbiotics in infants with suspected or confirmed CMPA in routine practice.
Methods
This was a prospective, multicenter, observational, single-arm real-world cohort study. Physicians recorded cow’s milk allergy symptom score (CoMiSS) and infant gastrointestinal symptom questionnaire (IGSQ-13) at baseline (Day 1) and Day 28. Caregivers completed the atopic dermatitis patient-oriented score (PO-SCORAD) and quality of life in food allergy-parental burden (FAQL-PB) at baseline and Day 28 and recorded stool, regurgitation, and discomfort at prespecified time points. One-year outcomes (growth and health resource use) were assessed descriptively among participants with available follow-up data.
Results
A total of 71 infants completed the 28-day observation period. Mean CoMiSS decreased from 10.1 (SD 4.6) at baseline to 3.5 (SD 2.2) on Day 28. Median IGSQ-13 and PO-SCORAD scores decreased over 28 days; FAQL-PB scores also decreased. Caregiver-reported stool frequency and regurgitation categories improved over time. One-year outcomes were available for 56 children and are reported descriptively.
Conclusion
In this prospective real-world cohort, symptom scores and caregiver-reported outcomes improved over 28 days following initiation of an amino acid-based formula containing synbiotics in infants managed for suspected/confirmed CMPA. Given the observational nature of the study, these findings should be interpreted cautiously and do not establish causality or comparative effectiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CEP Pediatric Specialty Clinics, San Miguel de Tucumán, Argentina.
- Belgrano R Pediatric Medical Center, Ciudad Autónoma de Buenos Aires, Argentina.
- Uriburu Pediatric Practice, Ciudad Autónoma de Buenos Aires, Argentina.
- Titiko Ume Private Practice, Corrientes, Argentina.
- Department of Gastroenterology, 9 de Julio Sanatorium, San Miguel de Tucumán, Argentina.
- Pediatric Consultation Clinic Dr. Plante, Ciudad Autónoma de Buenos Aires, Argentina.
Zitieren
APA
Soria, S. R., Malagrino, P., Sacconi, E., Martin, G., Rovati, N., Plante, V., Ursino, F. G., Biasoli, M. F., Petriz, N. A., Micone, P., Maciero, E., & Giglio, N. (2026). Amino acid-based formula with synbiotics for cow's milk protein allergy: a real-world study of symptom evolution and quality-of-life outcomes. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1864706
Vancouver
Soria SR, Malagrino P, Sacconi E, Martin G, Rovati N, Plante V, et al. Amino acid-based formula with synbiotics for cow's milk protein allergy: a real-world study of symptom evolution and quality-of-life outcomes. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1864706
BibTeX
@article{Soria2026,
author = {Soria, Sebastián Ramiro and Malagrino, Pablo and Sacconi, Estefanía and Martin, Graciela and Rovati, Nicolás and Plante, Verónica and Ursino, Florencia Grisel and Biasoli, María Florencia and Petriz, Natalia Alejandra and Micone, Paula and Maciero, Eugenia and Giglio, Norberto},
title = {Amino acid-based formula with synbiotics for cow's milk protein allergy: a real-world study of symptom evolution and quality-of-life outcomes},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1864706}
}
EUVIMED